Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Increased Writing Activity in Neurological Conditions:A Review and Clinical Study
JNNP 61:510-514, vanVugt,P.,et al, 1996
Treatment with Oral 3, 4 Diaminopyridine Improves Leg Strength in Multiple Sclerosis Patients
Neurol 47:1457-1462, Bever,C.T.,et al, 1996
Hypothermia in Multiple Sclerosis
JNNP 61:369-375, White,K.D.,et al, 1996
Long-Term Prog & Effect of Carotid Endarterectomy in Pts with Recurrent Ipsilat Ischemic Events
Neurol 47:1158-1162, Paddock-Eliasziw,L.M.,et al, 1996
Clinicopath Conf
Intravascular Lymphomatosis Involving Brain & Other Organs, Case 30-1996, NEJM 335:952-9596., , 1996
Prognosis After Stroke Followed by Surgical Closure of Patent Foramen Ovale
Neurol 47:1162-1166, Devuyst,G.,et al, 1996
Avoiding False Positive Diagnoses of Motor Neuron Disease:Lessons from the Scottish Motor Neuron Disease Register
JNNP 60:147-151, Davenport,R.J.,et al, 1996
Treatment of Refractory Urge Urinary Incontinence with Sacral Spinal Nerve Stimulation in Multiple Sclerosis Patients
Lancet 348:717-719, Bosch,J.L.&Broen,J., 1996
Serial MRI Studies in Pathologically Verified Balo's Concentric Sclerosis
J Comput Assist Tomogr 20:732-735, Chen,C-J.,et al, 1996
Cerebrovascular Complications of Fabry's Disease
Ann Neurol 40:8-17, Mitsias,P.&Levine,S.R., 1996
Clinical Profile of Patients with Epileptic and Nonepileptic Seizures
Neurol 46:1530-1533, Devinsky,O.,et al, 1996
Temporal Lobectomy for Refractory Epilepsy
JAMA 276:470-475, Sperling,M.R.,et al, 1996
Critical Illness Myopathy and Neuropathy
Lancet 347:1579-1582, Latronico,N.,et al, 1996
Early CT Signs in Acute Middle Cerebral Artery Infarction:Predictive Value for Subsequent Infarct Locations and Outcome
Neurol 47:366-375, Moulin,T.,et al, 1996
Multifocal Motor Neuropathy
JNNP 60:599-603, Nobile-Orazio,E., 1996
Is Chronic Respiratory Failure in Neuromuscular Diseases Worth Treating
JNNP 61:1-3, Shneerson,J.M., 1996
Motor Neuron Disease Presenting as Acute Respiratory Failure:A Clinical and Pathological Study
JNNP 60:455-458, Chen,R.,et al, 1996
Clinicopath Conf
Hypertension, MI, and Cerebral Infarctions with Pheochromocytoma, Am J Med 100:357-36496., , 1996
Inclusion Body Myositis
JNNP 60:251-255, Garlepp,M.J.&Mastaglia,F.L., 1996
Fever, Convulsions and Coma in Scleromyxedema:A"Dermato-Neuro Syndrome"
Neurol 46:1778-1779, River,Y.,et al, 1996
Evidence for Genetic Basis of Multiple Sclerosis
Lancet 347:1728-1730, Sadovnick,A.D.,et al, 1996
Clinical and Subclinical Neurological Involvement in Children of Conjugal Multiple Sclerosis Patients
Multiple Sclerosis 1:170-172, Constantinescu,C.S.,et al, 1996
Conduction Aphasia in Multiple Sclerosis:A Case Report with MRI Findings
Neurol 47:576-578, Arnett,P.A.,et al, 1996
Multiple Sclerosis of the Spinal Cord:Magnetic Resonance Appearance
J Comput Assist Tomogr 20:434-438, Thielan,K.R.&Miller,G.M., 1996
Sporadic Corticosteroid Pulses and Osteoporosis in Multiple Sclerosis
Arch Neurol 53:753-757, Schwid,S.R.,et al, 1996
Treatment of Secondary Progressive Multiple Sclerosis with the Immunomodulator Linomide:Study with Monthly MRI Evaluation
Neurol 47:341-346, Karussis,D.M.,et al, 1996
Impact of Aerobic Training on Fitness and Quality of Life in Multiple Sclerosis
Ann Neurol 39:432-441, 4221996., Petajan,J.H.,et al, 1996
Low Body Weight in Alzheimer's Disease is Associated with Mesial Temporal Cortex Atrophy
Neurol 46:1585-1591, Grundman,M.,et al, 1996
Risk of Cancer from Azathioprine Therapy in Multiple Sclerosis:A Case-Control Study
Neurol 46:1607-1612, Confavreux,C.,et al, 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Campylobacter Jejuni Infection and Anti-GM1 Antibodies in Guillain-Barre Syndrome
Ann Neurol 40:181-187, Jacobs,B.C.,et al, 1996
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Problems with Myofascial Pain Syndrome and Fibromyalgia Syndrome
Neurol 46:593-597, Bohr,T., 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
Pure Motor Hand Weakness
Semin Neurol 16:75-81, Lewis,R.A., 1996
Thalamic Haemorrhage
Brain 119:1873-1886, Chung,C-S.,et al, 1996
Periodic Lateralized Epileptiform Discharges in Multiple Sclerosis
Electroenceph Clin Neurophysiol 98:5-8, Shabolla,D.R.,et al, 1996
Long-term Prognosis in Cerebral Venous Thrombosis:Follow-up of 77 Patients
Stroke 27:243-246, Preter,M.,et al, 1996
Silent Brain Infarction in Nonrheumatic Atrial Fibrillation
EAFT Study Group, Neurol 46:159-1651996., , 1996
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Herpes Simplex Virus in Postmortem Multiple Sclerosis Brain Tissue
Arch Neurol 53:125-133, 1231996., Sanders,V.J.,et al, 1996
Clinicopath Conf
Cerebral Amyloid Angiopathy, Case 22-1996, NEJM 335:189-196996., , 1996
Thalamic Vascular Lesions, Risk Factors and Clinical Course for Infarcts and Hemorrhages
Stroke 27:1530-1536, del Mar Saez de Ocariz,M.,et al, 1996
Clinicopath Conf
Focal Cortical Dysplasia, Case 7-1996, NEJM 334:586-592996., , 1996
Stroke Recurrence in Patients with Patent Foramen Ovale:The Lausanne Study
Neurol 46:1301-1305, Bogousslavsky,J.,et al, 1996
Comparison of Triple Dose vs Std Dose Gadolinium-DTPA for Detect of MRI Enhanc Lesions in Pts with MS
Neurol 46:379-384, Filippi,M.,et al, 1996
Age and Guillain-Barre Syndrome Severity
Muscle & Nerve 19:375-377996., Sheth,R.D.,et al, 1996